Photo: The left picture shows Yang Guihua, chairman of Hualian Biotechnology, and the right picture shows Guan Jisheng, general manager of Cape Biotechnology, signing a memorandum of cooperation.
This time, the strategic partners of biotechnology manufacturers on both sides of the Taiwan Strait have formed an alliance, and it is planned to integrate Hualian Bio's experience in R&D 17 and its experience in producing high-density chips in Taiwan Province Province with Cape Bio's maternal and child clinical access platform at home and abroad. The two sides will focus on cooperation in CNV amniotic fluid chromosome chip detection and NIPT accurate non-invasive prenatal examination.
Figure: Hualian-Cape Bio-high-density Gene Chip Clinical Application and Industrialization Project-Signing Ceremony.
Yang Guihua, chairman of Hualian Bio, said: "We look forward to expanding the alliance with China biotechnology partners in the precision medical industry chain through platform technology transformation, and creating exclusive genetic testing services for China people. In addition, Cape Bio's product technology application covers nearly10.5 million domestic and foreign cooperative medical institutions, focusing on maternal and child genetic testing and birth defects. It is also a national biochip base and a national invention patent gold award enterprise specially recognized by the national strategic emerging industry development. In view of the strategic cooperation between the two parties, Guan Zhisheng, general manager of Cape Biotechnology, said: "We look forward to introducing new platforms and technologies, and continue to be committed to becoming the best testing partner for clinical experts and serving the country's maternal and child health. 」
The aCGH chromosome chip CytoOneArray product independently developed by Hualian Bio can screen more than 400 CNV chromosome disease regions at the same time, assist prenatal (pregnant women) and postpartum (newborns/children) screening, effectively detect chromosomal abnormalities, developmental retardation and mental retardation, and provide disease judgment basis for obstetricians and pediatricians. Through the alliance between Hualian and Cape, it is hoped that the two parties can jointly build a genetic testing service for women and children in China, effectively reducing the incidence of birth defects.
Hualian Biotechnology Knowledge+:
Hualian Bio has been deeply involved in Taiwan Province Province since 17, focusing on the research and development of gene detection platform, with gene detection and analysis technologies such as microarray, NGS and big data analysis. Hualian has the energy of self-research, self-design and self-production, and has continuously developed a variety of gene chips for disease risk detection and physical fitness detection, as well as providing early screening services for methylation of ctDNA liver cancer. At present, core gene testing services include:
First, clinical maternal and child medicine
CytoOneArray chromosome chip is used for prenatal and postnatal screening, and more than 400 CNV chromosome areas can be screened at the same time in one test. At the same time, combining the advantages of "CytoOneArray Chromosome Chip" and "Developmental Retardation Gene Analysis" Exon Sequencing (WES) technology, careful detection can effectively screen for chromosome copy number variation (CNV) and gene point mutation (SNVs) abnormalities in children or patients with developmental retardation.
Second, detection of SNP epidemic genes
The needle is specially designed for Asians, which combines congenital gene identification and acquired risk factor assessment. It is an exclusive probe of the same type. Services include:
Cancer risk gene detection (one evaluation 14 cases of male cancer or 15 cases of female cancer)
-Chronic disease risk gene detection (male 12 chronic disease or female 13 chronic disease).
–Obesity analysis gene detection (five quadrants, simultaneous analysis of single-gene and multi-gene obesity)
Third, scientific research/big data/translation science
Has a strong clinical research strength, and works closely with various medical centers and academic circles, and has published more than 300 papers. Hualian also provides commissioned design and processing services (ODM/OEM) for customized gene chips.
Title: aCGH chromosome chip, CNV amniotic fluid chromosome chip detection, NIPT precise non-invasive prenatal examination, Cape Biotechnology, Hualian Biotechnology.